Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome
Conditions
Interventions
ZX008 (Fenfluramine Hydrochloride)
Matching Placebo
Locations
55
United States
Phoenix Children's
Phoenix, Arizona, United States
Center for Neurosciences - Tucson
Tucson, Arizona, United States
Rady Children's Hospital San Diego
San Diego, California, United States
University of California San Francisco
San Francisco, California, United States
The Children's Hospital Colorado
Aurora, Colorado, United States
NW FL Clinical Research Group, LLC
Gulf Breeze, Florida, United States
Start Date
January 15, 2016
Primary Completion Date
July 29, 2020
Completion Date
July 29, 2020
Last Updated
September 28, 2023
NCT06872125
NCT05419492
NCT04462770
NCT06401538
NCT06598449
NCT06504511
Lead Sponsor
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions